Log In
BCIQ
Print this Print this
 

Bentamapimod

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionInhibitor of c-jun N-terminal kinase 1 (JNK1; MAPK8)
Molecular Target c-jun N-terminal kinase 1 (JNK1) (MAPK8)
Mechanism of Actionc-jun N-terminal kinase (JNK) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationEndometriosis
Indication DetailsTreat endometriosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/16/2010

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today